277 related articles for article (PubMed ID: 17680560)
1. 2-Methoxyestradiol attenuates phosphatidylinositol 3-kinase/Akt pathway-mediated metastasis of gastric cancer.
Lin HL; Yang MH; Wu CW; Chen PM; Yang YP; Chu YR; Kao CL; Ku HH; Lo JF; Liou JP; Chi CW; Chiou SH
Int J Cancer; 2007 Dec; 121(11):2547-55. PubMed ID: 17680560
[TBL] [Abstract][Full Text] [Related]
2. Hepatocyte growth factor (HGF) upregulates heparanase expression via the PI3K/Akt/NF-κB signaling pathway for gastric cancer metastasis.
Hao NB; Tang B; Wang GZ; Xie R; Hu CJ; Wang SM; Wu YY; Liu E; Xie X; Yang SM
Cancer Lett; 2015 May; 361(1):57-66. PubMed ID: 25727320
[TBL] [Abstract][Full Text] [Related]
3. Metastatic function of BMP-2 in gastric cancer cells: the role of PI3K/AKT, MAPK, the NF-κB pathway, and MMP-9 expression.
Kang MH; Oh SC; Lee HJ; Kang HN; Kim JL; Kim JS; Yoo YA
Exp Cell Res; 2011 Jul; 317(12):1746-62. PubMed ID: 21570392
[TBL] [Abstract][Full Text] [Related]
4. Combretastatin A4-induced differential cytotoxicity and reduced metastatic ability by inhibition of AKT function in human gastric cancer cells.
Lin HL; Chiou SH; Wu CW; Lin WB; Chen LH; Yang YP; Tsai ML; Uen YH; Liou JP; Chi CW
J Pharmacol Exp Ther; 2007 Oct; 323(1):365-73. PubMed ID: 17646428
[TBL] [Abstract][Full Text] [Related]
5. C-Type Lectin-Like Receptor 2 Suppresses AKT Signaling and Invasive Activities of Gastric Cancer Cells by Blocking Expression of Phosphoinositide 3-Kinase Subunits.
Wang L; Yin J; Wang X; Shao M; Duan F; Wu W; Peng P; Jin J; Tang Y; Ruan Y; Sun Y; Gu J
Gastroenterology; 2016 May; 150(5):1183-1195.e16. PubMed ID: 26855187
[TBL] [Abstract][Full Text] [Related]
6. BMP2 accelerates the motility and invasiveness of gastric cancer cells via activation of the phosphatidylinositol 3-kinase (PI3K)/Akt pathway.
Kang MH; Kim JS; Seo JE; Oh SC; Yoo YA
Exp Cell Res; 2010 Jan; 316(1):24-37. PubMed ID: 19835871
[TBL] [Abstract][Full Text] [Related]
7. CXCL10/CXCR3 axis promotes the invasion of gastric cancer via PI3K/AKT pathway-dependent MMPs production.
Zhou H; Wu J; Wang T; Zhang X; Liu D
Biomed Pharmacother; 2016 Aug; 82():479-88. PubMed ID: 27470388
[TBL] [Abstract][Full Text] [Related]
8. Expression of PI3K/AKT pathway in gastric cancer and its blockade suppresses tumor growth and metastasis.
Ye B; Jiang LL; Xu HT; Zhou DW; Li ZS
Int J Immunopathol Pharmacol; 2012; 25(3):627-36. PubMed ID: 23058013
[TBL] [Abstract][Full Text] [Related]
9. F-box protein 11 promotes the growth and metastasis of gastric cancer via PI3K/AKT pathway-mediated EMT.
Sun C; Tao Y; Gao Y; Xia Y; Liu Y; Wang G; Gu Y
Biomed Pharmacother; 2018 Feb; 98():416-423. PubMed ID: 29278851
[TBL] [Abstract][Full Text] [Related]
10. Clinicopathological significance of PI3K, Akt and survivin expression in gastric cancer.
Gu Y; Jin S; Wang F; Hua Y; Yang L; Shu Y; Zhang Z; Guo R
Biomed Pharmacother; 2014 May; 68(4):471-5. PubMed ID: 24726064
[TBL] [Abstract][Full Text] [Related]
11. Inhibition of PI3K/Akt partially leads to the inhibition of PrP(C)-induced drug resistance in gastric cancer cells.
Liang J; Ge F; Guo C; Luo G; Wang X; Han G; Zhang D; Wang J; Li K; Pan Y; Yao L; Yin Z; Guo X; Wu K; Ding J; Fan D
FEBS J; 2009 Feb; 276(3):685-94. PubMed ID: 19143835
[TBL] [Abstract][Full Text] [Related]
12. Rab7 Is Associated with Poor Prognosis of Gastric Cancer and Promotes Proliferation, Invasion, and Migration of Gastric Cancer Cells.
Liu H; Xu J; Yao Q; Zhang Z; Guo Q; Lin J
Med Sci Monit; 2020 Jun; 26():e922217. PubMed ID: 32591494
[TBL] [Abstract][Full Text] [Related]
13.
Qian Y; Yan Y; Lu H; Zhou T; Lv M; Fang C; Hou J; Li W; Chen X; Sun H; Li Y; Wang Z; Zhao N; Gu Y; Ding Y; Liu Y
Anticancer Agents Med Chem; 2019; 19(14):1754-1761. PubMed ID: 31364518
[TBL] [Abstract][Full Text] [Related]
14. Id-1 promotes tumorigenicity and metastasis of human esophageal cancer cells through activation of PI3K/AKT signaling pathway.
Li B; Tsao SW; Li YY; Wang X; Ling MT; Wong YC; He QY; Cheung AL
Int J Cancer; 2009 Dec; 125(11):2576-85. PubMed ID: 19551863
[TBL] [Abstract][Full Text] [Related]
15. ZNF143 enhances metastasis of gastric cancer by promoting the process of EMT through PI3K/AKT signaling pathway.
Wei S; Wang L; Zhang L; Li B; Li Z; Zhang Q; Wang J; Chen L; Sun G; Li Q; Xu H; Zhang D; Xu Z
Tumour Biol; 2016 Sep; 37(9):12813-12821. PubMed ID: 27449034
[TBL] [Abstract][Full Text] [Related]
16. ERp29 controls invasion and metastasis of gastric carcinoma by inhibition of epithelial-mesenchymal transition via PI3K/Aktsignaling pathway.
Ye J; Huang J; Xu J; Huang Q; Wang J; Zhong W; Lin X; Li Y; Lin X
BMC Cancer; 2017 Sep; 17(1):626. PubMed ID: 28874138
[TBL] [Abstract][Full Text] [Related]
17. Luteolin exerts a marked antitumor effect in cMet-overexpressing patient-derived tumor xenograft models of gastric cancer.
Lu J; Li G; He K; Jiang W; Xu C; Li Z; Wang H; Wang W; Wang H; Teng X; Teng L
J Transl Med; 2015 Feb; 13():42. PubMed ID: 25638174
[TBL] [Abstract][Full Text] [Related]
18. MiR-19a promotes epithelial-mesenchymal transition through PI3K/AKT pathway in gastric cancer.
Lu WD; Zuo Y; Xu Z; Zhang M
World J Gastroenterol; 2015 Apr; 21(15):4564-73. PubMed ID: 25914465
[TBL] [Abstract][Full Text] [Related]
19. Gastric cancer growth control by BEZ235 in vivo does not correlate with PI3K/mTOR target inhibition but with [18F]FLT uptake.
Fuereder T; Wanek T; Pflegerl P; Jaeger-Lansky A; Hoeflmayer D; Strommer S; Kuntner C; Wrba F; Werzowa J; Hejna M; Müller M; Langer O; Wacheck V
Clin Cancer Res; 2011 Aug; 17(16):5322-32. PubMed ID: 21712451
[TBL] [Abstract][Full Text] [Related]
20. PRL-3 promotes the peritoneal metastasis of gastric cancer through the PI3K/Akt signaling pathway by regulating PTEN.
Xiong J; Li Z; Zhang Y; Li D; Zhang G; Luo X; Jie Z; Liu Y; Cao Y; Le Z; Tan S; Zou W; Gong P; Qiu L; Li Y; Wang H; Chen H
Oncol Rep; 2016 Oct; 36(4):1819-28. PubMed ID: 27572739
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
